Drug Guide

Generic Name

Chlorothiazide

Brand Names Diuril

Classification

Therapeutic: Antihypertensive; Diuretic

Pharmacological: Thiazide diuretic

FDA Approved Indications

Mechanism of Action

Inhibits sodium reabsorption in the distal tubules of the kidney, leading to increased excretion of sodium, chloride, and water, thereby reducing blood volume and lowering blood pressure.

Dosage and Administration

Adult: Initial dose: 500 mg once daily or in two divided doses. Dose may be increased as needed, typically up to 2 g per day.

Pediatric: Not generally recommended for children due to lack of sufficient data.

Geriatric: Start at lower doses due to increased risk of hypotension and electrolyte imbalance; monitor closely.

Renal Impairment: Use with caution; may require dose adjustments and frequent monitoring.

Hepatic Impairment: Use with caution; avoid in severe impairment due to limited data.

Pharmacokinetics

Absorption: Well absorbed orally.

Distribution: Widely distributed, including into the cerebrospinal fluid; highly protein-bound.

Metabolism: Primarily unchanged in the urine; minimal hepatic metabolism.

Excretion: Renal excretion, mainly unchanged.

Half Life: Approximate plasma half-life of 7-14 hours.

Contraindications

Precautions

Adverse Reactions - Common

Adverse Reactions - Serious

Drug-Drug Interactions

Drug-Food Interactions

Drug-Herb Interactions

N/A

Nursing Implications

Assessment: Monitor blood pressure, serum electrolytes, renal function, hydration status.

Diagnoses:

  • Deficient fluid volume r/t excessive diuresis
  • Electrolyte imbalance, risk of hypokalemia

Implementation: Administer with meals to minimize gastrointestinal upset; monitor electrolyte levels regularly.

Evaluation: Assess blood pressure response, electrolyte levels, and signs of dehydration or electrolyte imbalance.

Patient/Family Teaching

Special Considerations

Black Box Warnings:

Genetic Factors: None specifically documented.

Lab Test Interference: May cause false elevation of serum uric acid or glucose levels.

Overdose Management

Signs/Symptoms: Severe electrolyte imbalance, dehydration, hypotension, dizziness, weakness.

Treatment: Discontinue drug, correct electrolyte imbalances with IV fluids and electrolytes, monitor vital signs and renal function.

Storage and Handling

Storage: Store at room temperature, away from moisture and light.

Stability: Stable under recommended storage conditions.

This guide is for educational purposes only and is not intended for clinical use.